Cite
HARVARD Citation
Schwartzberg, L. et al. (2020). Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial. Oncologist. pp. e1233-e1241. [Online].